Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells

Area of Science:

• Molecular Biology
• Genetics
• Cell Biology

Background:

• RNA interference (RNAi) is a gene silencing mechanism involving small interfering RNA (siRNA) that primarily occurs in the cytoplasm.
• Myotonic dystrophy type 1 (DM1) is characterized by a mutant DMPK gene producing nuclear-retained transcripts.

Purpose of the Study:

• To investigate the presence and mechanisms of RNAi in both cytoplasmic and nuclear compartments of primary human DM1 cells.
• To evaluate the efficacy of targeting nuclear-retained mutant DMPK mRNA using RNAi-based approaches.

Main Methods:

• Utilized primary human DM1 myoblasts with both wild-type and mutant DMPK transcripts.
• Employed lentivirus-delivered short hairpin RNAs (shRNAs) to target nuclear-retained mutant DMPK mRNA.
• Compared shRNA delivery with synthetic siRNA delivery via cationic lipids.

Main Results:

• Demonstrated the first instance of down-regulating endogenous nuclear-retained mutant DMPK mRNAs using shRNAs.
• Observed simultaneous RNAi activity on both cytoplasmic and nuclear DMPK transcripts.
• Found that nuclear RNAi(-like) effects were not achieved with synthetic siRNAs delivered by cationic lipids.

Conclusions:

• RNAi phenomena coexist in both cytoplasmic and nuclear compartments of mammalian cells.
• Nuclear RNAi targeting may involve distinct pathways or depend on shRNA processing and nuclear import.
• Findings have significant implications for understanding post-transcriptional gene regulation in mammalian cells.